# Reimagined Ventures

> Reimagined Ventures is a VC fund backing E-Commerce and Health Care. See 29 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Winnetka, United States
- Total investments: 29
- Last investment: Dec 2024
- Lead investor: 21%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/reimagined-ventures
- X (Twitter): https://twitter.com/ReimaginedVC
- Website: http://www.reimaginedventures.com/

Reimagined Ventures is a Chicago-based family office which invests across a range of industries and asset classes, with a specific focus on private capital, real estate, and business operations. We focus on finding the businesses and entrepreneurs who are upending the status quo and rethinking old ways to create something new.

## Contacts

5 contacts available for Reimagined Ventures. Shizune tracks 5 team members at Reimagined Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/reimagined-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| E-Commerce | 6 | 21% |
| Health Care | 5 | 17% |
| Biotechnology | 5 | 17% |
| Retail | 4 | 14% |
| Medical | 4 | 14% |

55 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 17% |
| Series B | 4 | 14% |
| Funding Round | 4 | 14% |
| Series C | 3 | 10% |
| Series D | 3 | 10% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 17 | 59% |
| Singapore | 1 | 3% |
| South Korea | 1 | 3% |
| United Kingdom | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jack Litowitz | Director of Strategic Investments | 3 | https://shizune.co/investors/profile/jack-litowitz |
| Alec Litowitz | Founder, CEO | 0 | https://shizune.co/investors/profile/alec-litowitz |
| Michael Carter | Head of Strategy | 0 | https://shizune.co/investors/profile/michael-carter-1988 |
| Monica Byrd | Head of Accounting | 0 | https://shizune.co/investors/profile/monica-byrd-46b1 |
| Monica Byrd | Head of Accounting | 0 | https://shizune.co/investors/profile/monica-byrd-b314 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cala Health | Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. |  |  | Dec 09, 2024 |  |
| Cala Health | Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. | $50M | Series C | Dec 09, 2024 |  |
| Vedanta Biosciences | Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts. | $106.5M | Series E | Apr 25, 2023 |  |
| TAE Technologies | TAE Technologies is leveraging proprietary science and engineering to tackle the world’s biggest challenges. Their core mission is to create a new source of clean energy – one that’s powered by nature’s own processes and produces no harmful byproducts. Their groundbreaking work has led to industry-wide advances in accelerator and plasma physics,and acted as a catalyst for adjacent innovations based on their results. With 20 years of focused research, TAE Technologies is on a purposeful path to commercial fusion energy and pioneering sustainable solutions for a better tomorrow. | $250M | Series G | Jul 19, 2022 |  |
| GrubMarket | GrubMarket develops a website where sellers can offer foods and other items at wholesale prices to customers. It offers products such as organic foods, vegetables, gluten-free foods, snacks, drinks, pantries, home goods, health and beauty products, baby and kids' products, pets, non-GMO foods, paleo foods, cholesterol-free, and no trans-fatfoods.GrubMarket also offers foods from local farms, fisheries, commercial kitchens, certified home kitchens, and restaurants. Mike Xu founded GrubMarket in 2014, with its headquarters in Newark in California with an additional office in San Francisco in California. | $200M | Series E | Nov 16, 2021 |  |
| Mekonos | Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip. Mekonos is a Silicon Valley Venture-backed technology company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in drug discovery and development. | $25M | Series A | Nov 09, 2021 |  |
| GrubMarket | GrubMarket develops a website where sellers can offer foods and other items at wholesale prices to customers. It offers products such as organic foods, vegetables, gluten-free foods, snacks, drinks, pantries, home goods, health and beauty products, baby and kids' products, pets, non-GMO foods, paleo foods, cholesterol-free, and no trans-fatfoods.GrubMarket also offers foods from local farms, fisheries, commercial kitchens, certified home kitchens, and restaurants. Mike Xu founded GrubMarket in 2014, with its headquarters in Newark in California with an additional office in San Francisco in California. | $145M | Series E | Oct 26, 2021 |  |
| NovaSignal | NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system. Robotic System combines non-invasive ultrasound, robotics, and artificial intelligence to assess real-time cerebral blood flow. NovaSignal’s assets were acquired and the company transitioned to NeuraSignal in June 2023. | $37M | Series C | Sep 28, 2021 |  |
| Outer | Outer is a direct-to-consumer outdoor furniture brand on a mission to bring life outside. The products are designed by former head furniture designer of Pottery Barn, Terry Lin and manufactured in CEO Jiake Liu's family-owned factory. Since its inception in 2017, Outer has increased its revenue 11 times by 2020 and tripled its workforce in thepast nine months. | $50M | Series B | Sep 16, 2021 |  |
| Arcadia | Arcadia is a nationwide home energy platform providing clean energy and savings. Arcadia Power is remaking the customer utility experience from the ground-up, and personalizing it. They offer customers seamless monthly billing, access to wind energy, community solar programs, and on-bill financing of energy efficient products. | $100M | Series D | Sep 15, 2021 |  |

10 of 29 investments shown.

## Co-investors
- [Fiscus Ventures](https://shizune.co/investors/profile/fiscus-ventures) — VC Fund, 4 deals together
- [Peak 6](https://shizune.co/investors/profile/peak6-investments) — VC Fund, 4 deals together
- [Action Potential Venture Capital](https://shizune.co/investors/profile/action-potential-venture-capital) — VC Fund, 3 deals together
- [Celtic House Asia Partners](https://shizune.co/investors/profile/celtic-house-asia-partners) — VC Fund, 3 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 3 deals together
- [INP Capital](https://shizune.co/investors/profile/inp-capital) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Reimagined Ventures invest in?

Reimagined Ventures invests primarily in E-Commerce, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Reimagined Ventures?

Public channels for Reimagined Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Reimagined Ventures?

The team at Reimagined Ventures includes Jack Litowitz (Director of Strategic Investments), Alec Litowitz (Founder, CEO) and Michael Carter (Head of Strategy). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co